Test environment running 7.6.3
 

nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications

dc.contributor.authorDoyle, Jasonen
dc.contributor.authorBrinkworth, Craig S.en
dc.contributor.authorWegener, Kate L.en
dc.contributor.authorCarver, John A.en
dc.contributor.authorLlewellyn, Lyndon E.en
dc.contributor.authorOlver, Ian N.en
dc.contributor.authorBowie, John H.en
dc.contributor.authorWabnitz, Paul A.en
dc.contributor.authorTyler, Michael J.en
dc.date.accessioned2025-03-25T21:23:48Z
dc.date.available2025-03-25T21:23:48Z
dc.date.issued2003en
dc.description.abstractA large number of bioactive peptides have been isolated from amphibian skin secretions. These peptides have a variety of actions including antibiotic and anticancer activities and the inhibition of neuronal nitric oxide synthase. We have investigated the structure - activity relationship of citropin 1.1, a broad-spectrum antibiotic and anticancer agent that also causes inhibition of neuronal nitric oxide synthase, by making a number of synthetically modified analogues. Citropin 1.1 has been shown previously to form an amphipathic α-helix in aqueous trifluoroethanol. The results of the structure - activity studies indicate the terminal residues are important for bacterial activity and increasing the overall positive charge, while maintaining an amphipathic distribution of residues, increases activity against Gram-negative organisms. Anticancer activity generally mirrors antibiotic activity suggesting a common mechanism of action. The N-terminal residues are important for inhibition of neuronal nitric oxide synthase, as is an overall positive charge greater than three. The structure of one of the more active synthetic modifications (A4K 14-citropin 1.1) was determined in aqueous trifluoroethanol, showing that this peptide also forms an amphipathic α-helix.en
dc.description.statustrueen
dc.format.extent13en
dc.identifier.otherScopus:0344211838en
dc.identifier.otherPubMed:12631273en
dc.identifier.urihttps://dspace-test.anu.edu.au/handle/1885/733737954
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=0344211838&partnerID=8YFLogxKen
dc.language.isoEnglishen
dc.sourceEuropean Journal of Biochemistryen
dc.subjectAntibacterialen
dc.subjectAnticanceren
dc.subjectCitropinen
dc.subjectnNOS activityen
dc.titlenNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modificationsen
dc.typeArticleen
local.bibliographicCitation.lastpage1153en
local.bibliographicCitation.startpage1141en
local.contributor.affiliationDoyle, Jason; Australian Institute of Marine Scienceen
local.contributor.affiliationBrinkworth, Craig S.; University of Adelaideen
local.contributor.affiliationWegener, Kate L.; University of Adelaideen
local.contributor.affiliationCarver, John A.; University of Wollongongen
local.contributor.affiliationLlewellyn, Lyndon E.; Australian Institute of Marine Scienceen
local.contributor.affiliationOlver, Ian N.; University of Adelaideen
local.contributor.affiliationBowie, John H.; University of Adelaideen
local.contributor.affiliationWabnitz, Paul A.; University of Adelaideen
local.contributor.affiliationTyler, Michael J.; University of Adelaideen
local.identifier.citationvolume270en
local.identifier.doi10.1046/j.1432-1033.2003.03462.xen
local.identifier.pureee87b42b-9572-4578-9091-d92f4f94b6b0en
local.type.statusPublisheden

Downloads